Biochemically, patients with poorer COVID-19 prognosis demonstrate increased liver and renal dysfunction [13] and elevated levels of inflammatory markers (ferritin, CRP, IL-6), coagulation markers (D-dimer, fibrinogen), cardiac markers (troponin I, LDH), and platelets, alongside distinct lipidomic changes [14]. Here, IL6 is linked to COVID-19.